Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  London Stock Exchange  >  GlaxoSmithKline plc    GSK   GB0009252882

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

GlaxoSmithKline plc : Director/PDMR Shareholding

share with twitter share with LinkedIn share with facebook
share via e-mail
0
05/03/2012 | 08:11pm CET

Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

I give below details of changes in the interests of a Person Discharging Managerial Responsibility in the Ordinary Shares of GlaxoSmithKline plc ("Ordinary Shares") on 2 May 2012:

Mr S M Bicknell

Transfer of 250 Ordinary Shares into an ISA at £14.3225 per share.



The Company and the above mentioned person was advised of this transaction on 3 May 2012.

This notification relates to a transaction notified in accordance with Disclosure Rule 3.1.4R(1)(a).

V A Whyte

Company Secretary

3 May 2012


This information is provided by RNS
The company news service from the London Stock Exchange
ENDRDSQXLFBLEFXBBD
distributed by
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on GLAXOSMITHKLINE PLC
01/18 Global Influenza Market Has Been Accelerated USD 6.87 Billion in 2020
01/18 Drugmakers in Davos shift focus to chronic diseases of poor
01/16 GLAXOSMITHKLINE PHARMACEUTICALS : Recovery ahead
01/10DJMAYNE PHARMA : Launches Foam Dermatology Products in US
01/05 BAT quits nicotine inhaler to focus on vaping
01/05 BAT quits nicotine inhaler to focus on vaping
01/04 GLAXOSMITHKLINE : *rpt/jpmorgan cuts glaxosmithkline price target to 1600 pence ..
01/03 GLAXOSMITHKLINE : *jpmorgan cuts glaxosmithkline price target to 1600 pence - 'n..
01/03 GLAXOSMITHKLINE : GSK Confirms Closure of Agreement to Divests Non-Core Assets t..
2016 EAGLE PHARMACEUTICALS : Announces David Pernock as President and Chief Commercia..
More news
Sector news : Pharmaceuticals - NEC
02:17aDJMALLINCKRODT : to Pay $100 Million to Settle Antitrust Allegations on Unlawful D..
01/18DJCSL : Expects Higher Profits On Strong Immunoglobulin Sales -- Update
01/18DJCSL : Expects Higher 1st Half Profits On Strong Immunoglobulin Sales
01/18DJMALLINCKRODT : to Pay $100 Million to Settle Antitrust Allegations on Unlawful D..
01/18DJELI LILLY AND : to Buy Migraine Drug Developer CoLucid Pharmaceuticals
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
01/18 Valeant Gives Up Gains
01/18 Tracking Ken Fisher's Fisher Asset Management Portfolio - Q4 2016 Update
01/17 AnaptysBio Sets Terms For $60 Million IPO
01/16 Why I Bought GlaxoSmithKline Recently
01/13 BIOTECHS : What The 'Trump Dump' And CVS's EpiPen Move May Mean
Advertisement
Financials ( GBP)
Sales 2016 27 567 M
EBIT 2016 7 224 M
Net income 2016 2 311 M
Debt 2016 13 807 M
Yield 2016 5,23%
P/E ratio 2016 32,81
P/E ratio 2017 18,99
EV / Sales 2016 3,26x
EV / Sales 2017 3,04x
Capitalization 76 180 M
More Financials
Chart GLAXOSMITHKLINE PLC
Duration : Period :
GlaxoSmithKline plc Technical Analysis Chart | GSK | GB0009252882 | 4-Traders
Full-screen chart
Technical analysis trends GLAXOSMITHKLINE PLC
Short TermMid-TermLong Term
TrendsBullishBearishNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 28
Average target price 17,7  GBP
Spread / Average Target 14%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Andrew Philip Witty Chief Executive Officer & Executive Director
Philip Roy Hampton Non-Executive Chairman
Simon Dingemans Chief Financial Officer & Executive Director
Birgitte Volck Head-Research & Development
Moncef Slaoui Executive Director & Chairman-Global Vaccines
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
GLAXOSMITHKLINE PLC-0.67%94 052
JOHNSON & JOHNSON-0.30%312 507
ROCHE HOLDING LTD.1.29%200 476
PFIZER INC.-1.29%194 551
NOVARTIS AG-2.70%185 185
MERCK & CO., INC.4.43%169 509
More Results